Last update 01 Nov 2024

Bevacizumab biosimilar(Cipla Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Bevacizumab Biosimilar (Cipla Ltd.), 贝伐珠单抗生物类似药(Cipla Ltd.)
+ [2]
Target
Mechanism
VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), Angiogenesis inhibitors
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Advanced Renal Cell Carcinoma
AU
02 Nov 2021
Breast cancer recurrent
AU
02 Nov 2021
High grade glioma
AU
02 Nov 2021
Metastatic breast cancer
AU
02 Nov 2021
Metastatic Cervical Carcinoma
AU
02 Nov 2021
Metastatic Colorectal Carcinoma
AU
02 Nov 2021
Metastatic Renal Cell Carcinoma
AU
02 Nov 2021
Non-squamous non-small cell lung cancer
AU
02 Nov 2021
Platinum-Resistant Epithelial Ovarian Carcinoma
AU
02 Nov 2021
Platinum-Resistant Fallopian Tube Carcinoma
AU
02 Nov 2021
Platinum-Resistant Primary Peritoneal Carcinoma
AU
02 Nov 2021
Recurrent Cervical Cancer
AU
02 Nov 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
metastatic non-small cell lung cancerNDA/BLA-01 Dec 2016
NeoplasmsNDA/BLA
NZ
01 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free